ENPP2 and multiple sclerosis: In this context, increased ATX and LPA levels have been reported in the sera and cerebrospinal fluid (CSF) of multiple sclerosis patients (108–110), while pharmacologic inhibition of ATX attenuated the development of experimental autoimmune encephalomyelitis (111).